Literature DB >> 14670580

Treatment of herpes simplex virus infections.

Rebecca C Brady1, David I Bernstein.   

Abstract

Herpes simplex virus (HSV) types 1 and 2 are ubiquitous organisms that cause infections in human populations throughout the world. The clinical manifestations of HSV infections are varied, ranging from asymptomatic disease to life-threatening illness in neonates and immunocompromised hosts. This article will review the common presentations for HSV disease and the current recommendations for the treatment of these infections. A detailed summary of the antiviral drugs used to treat HSV infections is also presented.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14670580     DOI: 10.1016/j.antiviral.2003.09.006

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  39 in total

1.  Herpes Simplex Virus-1 and -2 Rapid Detection in Whole Blood.

Authors:  Wei Zhen; Gregory J Berry
Journal:  Mol Diagn Ther       Date:  2021-01-01       Impact factor: 4.074

Review 2.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

Review 3.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

4.  A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells.

Authors:  Mohamed M Ali; Ghadah A Karasneh; Min Jung Jarding; Vaibhav Tiwari; Deepak Shukla
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

5.  The Importance of Heparan Sulfate in Herpesvirus Infection.

Authors:  Christopher D O'Donnell; Deepak Shukla
Journal:  Virol Sin       Date:  2008-12-01       Impact factor: 4.327

6.  Inhibition of herpes simplex virus type 1 with the modified green tea polyphenol palmitoyl-epigallocatechin gallate.

Authors:  Aline de Oliveira; Sandra D Adams; Lee H Lee; Sean R Murray; Stephen D Hsu; Jeffrey R Hammond; Douglas Dickinson; Ping Chen; Tin-Chun Chu
Journal:  Food Chem Toxicol       Date:  2012-11-23       Impact factor: 6.023

7.  Inhibition of herpes simplex virus-1 infection by MBZM-N-IBT: in silico and in vitro studies.

Authors:  Abhishek Kumar; Saikat De; Alok Kumar Moharana; Tapas Kumar Nayak; Tanuja Saswat; Ankita Datey; Prabhudutta Mamidi; Priyadarsee Mishra; Bharat Bhusan Subudhi; Soma Chattopadhyay
Journal:  Virol J       Date:  2021-05-26       Impact factor: 4.099

8.  Anti-Herpetic Activity of Callissia fragrans and Simmondsia chinensis Leaf Extracts In Vitro.

Authors:  Ludmila Yarmolinsky; Michele Zaccai; Shimon Ben-Shabat; Mahmoud Huleihel
Journal:  Open Virol J       Date:  2010-05-11

9.  Efficacy of Bidens pilosa Extract against Herpes Simplex Virus Infection In Vitro and In Vivo.

Authors:  Shinji Nakama; Kazumi Tamaki; Chie Ishikawa; Masayuki Tadano; Naoki Mori
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-28       Impact factor: 2.629

10.  Screening for antiviral activities of isolated compounds from essential oils.

Authors:  Akram Astani; Jürgen Reichling; Paul Schnitzler
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.